Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20367)

• Formulation Name: Spironolactone 100 mg tablet
• Company: State of Florida DOH Central Pharmacy

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Spironolactone	(DM2AQ5N)	Chronic heart failure	BD1Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Calcium sulfate anhydrous	(E00303)	24497	Desiccant; Diluent
Hypromellose	(E00634)	Not Available	Coating agent
Magnesium stearate	(E00208)	11177	lubricant
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Povidone	(E00667)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent